Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-09-16

Clinical Trial Update: Melatonin for Prevention of Post- Operative Delirium Pilot Study Protocol [Phase 4]

View source ↗

Summary

A Phase 4 pilot study protocol evaluating melatonin for preventing postoperative delirium has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Loyola University | Conditions: Delirium | Phase 4 | Status: WITHDRAWN